Top

Chinese Journal of Cancer Research

Published in:

01-09-2011 | Original Article

Combination of recombinant adenovirus-p53 with radiochemotherapy in unresectable pancreatic carcinoma

Authors: Jin-luan Li, Yong Cai, Shan-wen Zhang, Shao-wen Xiao, Xiao-fan Li, You-jia Duan, Yong-heng Li, Bo Xu, Kun Yan

Published in: Chinese Journal of Cancer Research | Issue 3/2011

Title: Combination of recombinant adenovirus-p53 with radiochemotherapy in unresectable pancreatic carcinoma
Authors: Jin-luan Li
Yong Cai
Shan-wen Zhang
Shao-wen Xiao
Xiao-fan Li
You-jia Duan
Yong-heng Li
Bo Xu
Kun Yan
Publication date: 01-09-2011
Publisher: Chinese Anti-Cancer Association
Published in: Chinese Journal of Cancer Research / Issue 3/2011
Print ISSN: 1000-9604
Electronic ISSN: 1993-0631
DOI: https://doi.org/10.1007/s11670-011-0194-0

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2011

Src is dephosphorylated at tyrosine 530 in human colon carcinomas

Determination of PDCD5 in peripheral blood serum of cancer patients

Sorafenib combined with cryoablation to treat unresectable hepatocellular carcinoma

Oxaliplatin-induced lung injury with allergic reaction

XRCC1 polymorphisms and pancreatic cancer: A meta-analysis

Pilomyxoid astrocytoma in cerebellum

Keynote webinar | Spotlight on antibody–drug conjugates in cancer